zepbound and tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity Food and Drug Administration (FDA) in 2021 for the treatment of type 2 diabetes Eli Lilly's Zepbound Gets FDA
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

























